Fredrik Andreas Fineide

Dr. Fredrik Andreas Fineide

Tørreøyneklinikken
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in The Ocular Surface
Verified
Journal Article
Open access
BTBehzod Tashbayev
Behzod Tashbayev
Mazyar YazdaniMazyar Yazdani
Mazyar Yazdani
RAReiko Arita
Reiko Arita
FFFredrik Andreas Fineide
Fredrik Andreas Fineide
TUTor Paaske Utheim
Tor Paaske Utheim
To review the published literature related to application of intense pulsed light (IPL) for treating meibomian gland dysfunction (MGD). The literature search included the PubMed database and used the keywords "Intense Pulsed Light and Meibomian Gland Dysfunction". IPL is a new instrumental treatment modality for MGD. This treatment modality was originally developed for use in dermatology and was later adopted in ophthalmology for treating MGD. IPL therapy for MGD can improve tear film stability, meibomian gland functionality, as well as subjective feeling of ocular dryness. However, in the reviewed literature, there was great variability in patient selection, evaluation criteria, and treatment protocols and durations. Numerous studies report that IPL is effective for treating MGD and a safe procedure. There is great potential for further improvements to the procedure, as large comparative studies employing different treatment modalities are lacking.

31 July 2022 in The Ocular Surface
Verified
Journal Article
Open access
FFFredrik Andreas Fineide
Fredrik Andreas Fineide
NLNeil Lagali
Neil Lagali
MAMuhammed Yasin Adil
Muhammed Yasin Adil
RAReiko Arita
Reiko Arita
MKMiriam Kolko
Miriam Kolko
TUTor P. Utheim
Tor P. Utheim
Glaucoma is a leading cause of irreversible blindness. The use of topical eye drops to reduce intraocular pressure remains the mainstay treatment. These eye drops frequently contain preservatives designed to ensure sterility of the compound. A growing number of clinical and experimental studies report the detrimental effects of not only these preservatives but also the active pharmaceutical compounds on the ocular surface, with resultant tear film instability and dry eye disease. Herein, we critically appraise the published literature exploring the effects of preservatives and pharmaceutical compounds on the ocular surface.

1 January 2021 in The Ocular Surface
Verified
Journal Article
Closed access
FFFredrik Andreas Fineide
Fredrik Andreas Fineide
RAReiko Arita
Reiko Arita
TUTor P. Utheim
Tor P. Utheim

Verified
Journal Article
Open access
PDF file
FFFredrik Andreas Fineide
Fredrik Andreas Fineide
XCXiangjun Chen
Xiangjun Chen
TBThomas Bjellaas
Thomas Bjellaas
VVValeria Vitelli
Valeria Vitelli
TUTor Paaske Utheim
Tor Paaske Utheim
HGHilde Kanli Galtung
Hilde Kanli Galtung
The diagnostic work-up of primary Sjögren’s syndrome (pSS) includes quantifying saliva and tear production, evaluation of autoantibodies in serum and histopathological analysis of minor salivary glands. Thus, the potential for further utilizing these fluids and tissues in the quest to find better diagnostic and therapeutic tools should be fully explored. Ten samples of saliva and tears from female patients diagnosed with pSS and ten samples of saliva and tears from healthy females were included for lipidomic analysis of tears and whole saliva using high-performance liquid chromatography coupled to time-of-flight mass spectrometry. In addition, lipidomic analysis was performed on minor salivary gland biopsies from three pSS and three non-SS females. We found significant differences in the lipidomic profiles of saliva and tears in pSS patients compared to healthy controls. Moreover, there were differences in individual lipid species in stimulated saliva that were comparable to those of glandular biopsies, representing an intriguing avenue for further research. We believe a comprehensive elucidation of the changes in lipid composition in saliva, tears and minor salivary glands in pSS patients may be the key to detecting pSS-related dry mouth and dry eyes at an early stage. The identified differences may illuminate the path towards future innovative diagnostic methodologies and treatment modalities for alleviating pSS-related sicca symptoms.

10 December 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FFFredrik Andreas Fineide
Fredrik Andreas Fineide
ASAndrea Marheim Storås
Andrea Marheim Storås
XCXiangjun Chen
Xiangjun Chen
MMMorten S. Magnø
Morten S. Magnø
AYAnis Yazidi
Anis Yazidi
TUTor Paaske Utheim
Tor Paaske Utheim
Dry eye disease is one of the most common ophthalmological complaints and is defined by a loss of tear film homeostasis. Establishing a diagnosis can be time-consuming, resource demanding and unpleasant for the patient. In this pilot study, we retrospectively included clinical data from 431 patients with dry eye disease examined in the Norwegian Dry Eye Clinic to evaluate how artificial intelligence algorithms perform on clinical data related to dry eye disease. The data was processed and subjected to numerous machine learning classification algorithms with the aim to predict decreased tear film break-up time. Moreover, feature selection techniques (information gain and information gain ratio) were applied to determine which clinical factors contribute most to an unstable tear film. The applied machine learning algorithms outperformed baseline classifications performed with ZeroR according to included evaluation metrics. Clinical features such as ocular surface staining, meibomian gland expressibility and dropout, blink frequency, osmolarity, meibum quality and symptom score were recognized as important predictors for tear film instability. We identify and discuss potential limitations and pitfalls.

13 September 2023 in Acta Ophthalmologica
Verified
Journal Article
Open access
FFFredrik Andreas Fineide
Fredrik Andreas Fineide
MMMorten S. Magnø
Morten S. Magnø
AKAyyad Zartasht Khan
Ayyad Zartasht Khan
XCXiangjun Chen
Xiangjun Chen
JVJelle Vehof
Jelle Vehof
TUTor P. Utheim
Tor P. Utheim
Dry eye disease is a highly prevalent condition, which can substantially impair quality of life, work productivity, and vision. It is considered an inflammatory disease and the most common cause is meibomian gland dysfunction. Despite many treatment alternatives being available, including artificial tears, warm compresses, antibiotics, and anti‐inflammatory therapy, lasting treatment effects are rare. Over the last two decades, intense pulsed light therapy, after being well established in dermatology, has been gradually introduced to the field of ophthalmology to treat meibomian gland dysfunction. The purpose of the current article is to critically review the clinical studies assessing the use of intense pulsed light to treat meibomian gland dysfunction published to date. The vast majority of the included studies demonstrated improved symptoms and signs, although the degree of efficacy and its duration varied greatly depending on concomitant treatment, number of treatment sessions, and other factors. Several possible mechanisms of action concerning disease propagation and treatment efficacy are discussed. There is still a need for larger, randomised, longitudinal studies to define the most efficacious treatment regime and to predict which patients may benefit the most. More studies are needed on implementing biochemical analyses and machine learning algorithms. Such studies may prove beneficial in predicting treatment effects, defining optimal treatment regimens, and furthering our understanding of the mechanisms of action.